Drug Profile
Research programme: clade C type HIV vaccines - GeoVax Labs
Alternative Names: C-DNA/MVA; C-MVA; GOVX C 11; GOVX C55Latest Information Update: 22 Apr 2022
Price :
$50
*
At a glance
- Originator GeoVax Labs
- Class AIDS vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 22 Apr 2022 Clade C type HIV vaccines are available for licensing as of 22 Apr 2022. https://www.geovax.com/
- 22 Apr 2022 Discontinued - Preclinical for HIV infections (Prevention) in USA, Africa (Parenteral)
- 28 Dec 2021 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in Africa (Parenteral)